1. HBW Insight
  2. >>Health
  3. >>Business
  4. >>Strategy

David Vs Goliath – Flarin’s Macmillen On Slugging It Out With The Heavyweights

 
• By David Ridley

HBW Insight Exclusive: Flarin boss Andrew Macmillen on competing with the big OTC incumbents as a lean, innovation-focused company.

Box fighters trainning outdoor . Mixed media
• Source: Shutterstock

With its unique lipid technology, UK ibuprofen brand Flarin has been increasing market share up against heavy hitting brands like GlaxoSmithKline’s Voltarol and Reckitt Benckiser’s Nurofen since launching at the beginning of 2018.

Relying on lipids – a macrobiomolecule derived from pharmaceutical-grade fats of plant origin – rather than water-based liquids for delivery,...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Strategy

Moberg Nail Fungus Line Takes Lead In Norway As Firm Plots EU Expansion

 
• By Tom Gallen

Terclara - Moberg’s proprietary topical formulation of terbinafine for fungal nail - has established itself as the market leader in Norway just months after its OTC launch. The firm is now plotting its expansion to additional EU markets.

US Consumer Health Sector Vigilant To Avoid Stumbling On Trump’s Tariff Twists And Turns

 
• By Malcolm Spicer

In remarks at recent investor conference reflecting comments from across the US consumer health sector, Kenvue chief Thibaut Mongon says, “I'm going to state the obvious. The environment is very fluid.”

AESGP Annual Meeting: Consumer Health Sector Still Safe Bet For Investors

 
• By David Ridley

A healthy diversity of different types of players and plenty of space for scaling up are among the reasons that investors remain interested in the consumer health sector, according to investment bankers speaking at the recent AESGP Annual Meeting.

People On The Move: Appointments At AESGP, PGEU, Nicapur

 
• By Tom Gallen

A round-up of the latest European health & wellness appointments: Workman re-elected AESGP chair; PGEU names 2026 leadership; Nicapur gets managing director.

More from Business

AESGP Annual Meeting: Consumer Health Sector Still Safe Bet For Investors

 
• By David Ridley

A healthy diversity of different types of players and plenty of space for scaling up are among the reasons that investors remain interested in the consumer health sector, according to investment bankers speaking at the recent AESGP Annual Meeting.

People On The Move: Appointments At AESGP, PGEU, Nicapur

 
• By Tom Gallen

A round-up of the latest European health & wellness appointments: Workman re-elected AESGP chair; PGEU names 2026 leadership; Nicapur gets managing director.

Germany’s PharmaSGP To Be Taken Private

 
• By Tom Gallen

Consumer health player PharmaSGP will be taken private by its biggest shareholder, FUTRUE.